by Jared Friedman5/17/2022

Today, we’re opening up registration for Startup School 2022, a live, online course where YC Group Partners and successful YC founders teach you how to build a billion dollar company.

by Jared Friedman9/17/2021

Ginkgo Bioworks is the first biotech company YC funded, and today they are going public. To celebrate their IPO, here’s the story of how Ginkgo Bioworks ended up in YC, and what their journey was like as YC’s first biotech startup.

by Jared Friedman10/28/2020

This is advice for people who have done scientific research at a university and are considering starting a company to commercialize it.

by Jared Friedman10/14/2020

Shasqi is the first YC Bio company to start first-in-human clinical trials for a drug.

by Jared Friedman3/25/2020

In order to confront the COVID-19 crisis, we need to immediately mobilize global scientific and technical talent. There are already a number of YC companies that are helping with the crisis, and we’re looking for more startups that, if successful, could alter the trajectory of COVID-19. We’re particularly interested in startups working on:

by Jared Friedman9/16/2019

Ginkgo Bioworks was the first bio company YC funded, back in summer 2014, which makes us especially delighted to announce a new partnership between YC and Ginkgo.

by Jared Friedman8/5/2019

Back when YC was getting started about 10 years ago, Paul Graham wrote some essays that predicted the way startup fundraising would change in the next decade – accurately, it turns out. Paul Graham predicted that there would be way more startups, that they’d be cheaper to start, that new kinds of investors would fund them, that founders would be more technical, and that founders would keep control of their companies. All of those seem to have come true.